• Non ci sono risultati.

Dottessa Iris Parrini

N/A
N/A
Protected

Academic year: 2022

Condividi "Dottessa Iris Parrini"

Copied!
24
0
0

Testo completo

(1)

Z/dD/͗

hEEhKsKW/dK>K

E>>Z/KdK^^//d͛

Dottessa Iris Parrini

Ospedale Mauriziano Torino

(2)

ŽŵĂŶĚĞ͗

`ŽŵĞƐŝĚĞĨŝŶŝƐĐĞŝůYd

`WĞƌĐŚĠŝůYdůƵŶŐŽĐŝĨĂƉĂƵƌĂ

`YƵĂůŝƐŽŶŽůĞĐĂƵƐĞĚŝYdůƵŶŐŽ

`ŚĞĐŽƐĂĨĂƉƌĞĐŝƉŝƚĂƌĞƵŶƋƵĂĚƌŽĚŝYdůƵŶŐŽ

(3)

͛ů͛ĞƐƉƌĞƐƐŝŽŶĞĚĞůůĂƌŝƉŽůĂƌŝnjnjĂnjŝŽŶĞ

ŵŝŽĐĂƌĚŝĐĂǀĞŶƚƌŝĐŽůĂƌĞ

ŽŵĞƐŝĚĞĨŝŶŝƐĐĞŝůYd͍

(4)

ŝĐŽƐĂŚŽďŝƐŽŐŶŽ͗

` 'ŝŶϭϮĐŽŶŝůĐĂůĐŽůŽĚĞůYdĐŽƌƌĞƚƚŽ

(5)

sĂůŽƌŝ ŶŽƌŵĂůŝƉĞƌůĂĚŝĂŐŶŽƐŝĚŝYdůƵŶŐŽ

ƵƚŝůŝnjnjĂŶĚŽůĂĨŽƌŵƵůĂĚŝ ĂnjĞƚƚ͛Ɛ

^ĞƐƐŽ ŵĂƐĐŚŝůĞ ^ĞƐƐŽ ĨĞŵŵŝůĞ

EŽƌŵĂůĞ фϰϯϬ ŵƐĞĐ фϰϱϬ ŵƐĞĐ

ŽƌĚĞƌůŝŶĞ ϰϯϬʹϰϱϬ ŵƐĞĐ ϰϱϬʹϰϳϬ ŵƐĞĐ

WƌŽůƵŶŐĂƚŽ хϰϱϬ ŵƐĞĐ хϰϳϬ ŵƐĞĐ

(6)

WĞƌĐŚĠŝůYdůƵŶŐŽĐŝĨĂƉĂƵƌĂ

/E

OUT K Ca

Na Accumulo di calcio

(esacerbato da

catecolamine)

(7)

^/EKW

DKZd/DWZKss/^

ŚŝğĂƌŝƐĐŚŝŽ

Z/KWd/͗

/^,D/

/>dd/s

/WZdZK&/

'Ed/

hKZ^EK

(8)

Yh>/^KEK>h^͗EhDZK^/&ddKZ/WK^^KEK

/EdZ&Z/ZdZD/EEKhE>>h'DEdK>Yd

KE//KE/KͲ^/^dEd/

KDW>/E

KZZ>d

>>dZW/

KEK>K'/

dZW/KEKD/dEd/

dZW/

Ed/EZK

QT

prolungato

(9)

EhDZK^/&ddKZ/WK^^KEK/EdZ&Z/ZdZD/EEK

hE>>h'DEdK>Yd

KE//KE/KͲ^/^dEd/

KDW>/E

KZZ>d

>>dZW/

KEK>K'/

dZW/

KEKD/dEd/

dZW/

Ed/EZK

QT prolungato

ƒ ĞƚăĂǀĂŶnjĂƚĂ

ƒ ƐĞƐƐŽĨĞŵŵŝŶŝůĞ

ƒ ŝƉŽƚŝƌŽŝĚŝƐŵŽ

ƒ ^ŝŶĚƌŽŵĞĚĞůYdůƵŶŐŽĐŽŶŐĞŶŝƚĂ ŵĂůĂƚƚŝĂĐĂƌĚŝĂĐĂ

ƒ ĚŝƐĨƵŶnjŝŽŶĞǀĞŶƚƌŝĐŽůĂƌĞƐŝŶŝƐƚƌĂ

ƒ ŝƐĐŚĞŵŝĂĐĂƌĚŝĂĐĂ

ƒ ďƌĂĚŝĐĂƌĚŝĂ

(10)

EhDZK^/&ddKZ/WK^^KEK/EdZ&Z/ZdZD/EEK

hE>>h'DEdK>Yd

KE//KE/KͲ^/^dEd/

,D/KdZW// ,WK^^KEK

dZD/EZhEYd>hE'K

,ŝƐƚŽŶĞ ĚĞĂĐĞƚLJůĂƐĞ ŝŶŚŝďŝƚŽƌƐ sŽƌŝŶŽƐƚĂƚ

DƵůƚŝƚĂƌŐĞƚĞĚ ƚLJƌŽƐŝŶĞŬŝŶĂƐĞ ŝŶŚŝďŝƚŽƌƐ

^ƵŶŝƚŝŶŝď ƐŽƌĂŶĞĨŝď

KDW>/E

KZZ>d

>>dZW/

KEK>K'/

dZW/

KEKD/dEd/

dZW/

Ed/EZK

QT prolungato

ƐŽƌĂŶĞĨŝď

ZͲ>ŝŶŚŝďŝƚŽƌƐ

ĂƐĂƚŝŶŝď EŝůŽƚŝŶŝď sĂŶƚĞŶĂŶŝď

ƌďͲϭͬͲϮƌĞĐĞƉƚŽƌƐŝŶŚŝďŝƚŽƌƐ

>ĂƉĂƚŝŶŝď

WƌŽƚĞĂƐŽŵĞ ŝŶŚŝďŝƚŽƌƐ

ŽƌƚĞnjŽŵŝď DŝƐĐĞůůĂŶĞŽƵƐ

ƌƐĞŶŝĐ ƚƌŝŽdžŝĚĞ

(11)

EhDZK^/&ddKZ/WK^^KEK/EdZ&Z/ZdZD/EEK

hE>>h'DEdK>Yd

KE//KE/KͲ

^/^dEd/

ŽŵƉůŝĐĂŶnjĞĐŽƌƌĞůĂƚĞĂůůĂƚĞƌĂƉŝĂ

ŽŶĐŽůŽŐŝĐĂ

ƒ /ƉŽŬĂůĞŵŝĂ͕/ƉŽŵĂŐŶĞƐĞŵŝĂ͕/ƉŽĐĂůĐĞŵŝĂ

ƒ ŝƐĨƵŶnjŝŽŶĞ ĞƉĂƚŝĐĂ ĞƌĞŶĂůĞ

ƒ EĂƵƐĞĂ͕ǀŽŵŝƚŽ͕ĚŝĂƌƌĞĂ

KDW>/E

KZZ>d

>>dZW/

KEK>K'/

dZW/

KEKD/dEd/

dZW/

Ed/EZK

QT prolungato

ƒ EĂƵƐĞĂ͕ǀŽŵŝƚŽ͕ĚŝĂƌƌĞĂ

ƒ ^ĐĂƌƐŽ ĐŽŶƚƌŽůůŽ ŐůŝĐĞŵŝĐŽ

ƒ ĚĞŝĚƌĂƚĂnjŝŽŶĞ͕ĚĞŶƵƚƌŝnjŝŽŶĞ

(12)

EhDZK^/&ddKZ/WK^^KEK/EdZ&Z/ZdZD/EEK

hE>>h'DEdK>Yd

KE//KE/KͲ^/^dEd/

&ĂƌŵĂĐŝƉŽƚĞŶnjŝĂůŵĞŶƚĞĂƌŝƐĐŚŝŽĚŝƉƌŽůƵŶŐĂƌĞů͛ŝŶƚĞƌǀĂůůŽYd͘

&ĂƌŵĂĐŝ

ĐĂƌĚŝŽǀĂƐĐŽůĂƌŝ

ŵŝŽĚĂƌŽŶĞ

ŚŝŶŝĚŝŶĂ

ŝƐŽƉŝƌĂŵŝĚĞ

ŽďƵƚĂŵŝŶĂ

ŽƉĂŵŝŶĂ

ĨĞĚƌŝŶĂ

ƉŝŶĞĨƌŝŶĂ

&ůĞĐĂŝŶŝĚĞ /ďƵƚŝůŝĚĞ

&ĂƌŵĂĐŝ^E

ůŽƉĞƌŝĚŽůŽ

ŵŝƚƌŝƉƚŝůŝŶĂ

ŝƚĂůŽƉƌĂŵ

ůŽƌĂůŝŽŝĚƌĂƚŽ

ůŽƌƉƌŽŵĂnjŝŶĂ

ůŽŵŝƉƌĂŵŝŶĂ

ƌŽƉĞƌŝĚŽůŽ

&ĞůďĂŵĂƚŽ

&ůƵŽdžĞƚŝŶĂ 'ĂůĂŶƚĂŵŝŶĂ

KůĂŶnjĂƉŝŶĂ WĂƌŽdžĞƚŝŶĂ YƵĞƚŝĂƉŝŶĂ ZŝƐƉĞƌŝĚŽŶĞ

^ĞƌƚŝŶĚŽůŽ

^ĞƌƚƌĂůŝŶĂ dŝŽƌŝĚĂnjŝŶĂ dŝnjĂŶŝĚŝŶĂ dƌŝŵŝƉƌĂŵŝŶĂ sĞŶůĂĨĂdžŝŶĂ

&ĂƌŵĂĐŝ'/

&ĂƌŵĂĐŝ

ƌĞƐƉŝƌĂƚŽƌŝŽ

^ĂůďƵƚĂŵŽůŽ

^ĂůŵĞƚĞƌŽůŽ dĞƌďƵƚĂůŝŶĂ

&ĂƌŵĂĐŝ

ĂŶƚŝďĂƚƚĞƌŝĐŝ

njŝƚƌŽŵŝĐŝŶĂ

ŝƉƌŽĨůŽdžĂĐŝŶĂ

ůĂƌŝƚƌŽŵŝĐŝŶĂ

ƌŝƚƌŽŵŝĐŝŶĂ

&ĂƌŵĂĐŝ

ĂŶƚŝǀŝƌĂůŝ

ŵĂŶƚŝĚŝŶĂ

&ŽƐĐĂƌŶĞƚ

&ĂƌŵĂĐŝ

ĂŶƚŝƉĂƌĂƐƐŝƚĂƌŝ

ůŽƌŽĐŚŝŶĂ DĞĨůŽĐŚŝŶĂ WĞŶƚĂŵŝĚŝŶĂ

&ĂƌŵĂĐŝ

&ĂƌŵĂĐŝ

ĚĞĐŽŶŐĞƐƚŝŽŶĂŶƚŝ

ŶĂƐĂůŝĞ

ĂŶƚŝƐƚĂŵŝŶŝĐŝ

&ĞŶŝůĞĨƌŝŶĂ

&ĞŶŝůƉƌŽƉĂŶŽůĂŵŝŶĂ WƐĞƵĚŽĞĨĞĚƌŝŶĂ dĞƌĨĞŶĂĚŝŶĂ

ůƚƌŝĨĂƌŵĂĐŝ

ůĨƵnjŽƐŝŶĂ KĐƚƌĞŽƚŝĚĞ

KDW>/E

KZZ>d

>>dZW/

KEK>K'/

dZW/KEKD/dEd/

dZW/

Ed/EZK

QT prolungato /ďƵƚŝůŝĚĞ

/ŶĚĂƉĂŵŝĚĞ /ƐƌĂĚŝƉŝŶĂ DŝĚŽĚƌŝŶĂ EŽƌĞƉŝŶĞĨƌŝŶĂ

^ŽƚĂůŽůŽ

'ĂůĂŶƚĂŵŝŶĂ /ŵŝƉƌĂŵŝŶĂ

>ĞǀŽŵĞƉƌŽŵĂnjŝŶĂ

>ŝƚŝŽ

DĞƚĂĚŽŶĞ DĞƚŝůĨĞŶŝĚĂƚŽ EŽƌƚƌŝƉƚŝůŝŶĂ

&ĂƌŵĂĐŝ'/

ŽůĂƐĞƚƌŽŶ

ŽŵƉĞƌŝĚŽŶĞ 'ƌĂŶŝƐĞƚƌŽŶ KŶĚĂŶƐĞƚƌŽŶ

ƌŝƚƌŽŵŝĐŝŶĂ

>ĞǀŽĨůŽdžĂĐŝŶĂ DŽdžŝĨůŽdžĂĐŝŶĂ KĨůŽdžĂĐŝŶĂ

ŽƚƌŝŵŽƐƐĂnjŽůŽ

&ĂƌŵĂĐŝ

ĂŶƚŝŵŝĐŽƚŝĐŝ

&ůƵĐŽŶĂnjŽůŽ /ƚƌĂĐŽŶĂnjŽůŽ

<ĞƚŽĐŽŶĂnjŽůŽ sŽƌŝĐŽŶĂnjŽůŽ

KĐƚƌĞŽƚŝĚĞ

^ŝďƵƚƌĂŵŝŶĂ dĂĐƌŽůŝŵƵƐ dĂŵŽdžŝĨĞŶĞ sĂƌĚĞŶĂĨŝů

(13)

YdĐ ŝŶƚĞƌǀĂůůŽ ĐŽƌƌĞůĂƚŽ ĂůŐƌĂĚŽ Ěŝ ƚŽƐƐŝĐŝƚă

YdĐ ƉƌŽůŽŶŐĂƚŝŽŶ 'ƌĂĚĞ ĞĨŝŶŝƚŝŽŶ

'ƌĂĚĞ / YdĐ хϰϱϬʹ ϰϳϬ ŵƐ

'ƌĂĚĞ // YdĐ хϰϱϬʹϱϬϬ ŵƐŽƌԜхԜϲϬ ŵƐĂďŽǀĞ

ďĂƐĞůŝŶĞ

'ƌĂĚĞ /// YdĐхϱϬϬ ŵƐ

'ƌĂĚĞ/s

YdĐхϱϬϬ ŵƐ͖ůŝĨĞͲƚŚƌĞĂƚĞŶŝŶŐƐŝŐŶƐŽƌ

ƐLJŵƉƚŽŵƐ;ƐLJŶĐŽƉĞ͕ƐŚŽĐŬ͕

ŚLJƉŽƚĞŶƐŝŽŶ͕ĂƌƌŚLJƚŚŵŝĂ͕ŚĞĂƌƚĨĂŝůƵƌĞͿ ŚLJƉŽƚĞŶƐŝŽŶ͕ĂƌƌŚLJƚŚŵŝĂ͕ŚĞĂƌƚĨĂŝůƵƌĞͿ

'ƌĂĚĞ s ĞĂƚŚ

ŽŵŵŽŶƚĞƌŵŝŶŽůŽŐLJ ĐƌŝƚĞƌŝĂ ĨŽƌ ĂĚǀĞƌƐĞ ĞǀĞŶƚƐ ǀϯ͘Ϭ;dͿ͕YdƉƌŽůŽŶŐĂƚŝŽŶ

QTc >500 milliseconds o variazione >60 milliseconds rispetto al basale:

sono i comuni criteri utilizzati quale indice di cardiotossicità

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use: The clinical evaluation of QT/QTc prolongation and pro-arrhythmic potential for non-antiarrhythmic drugs: E14. Geneva, Switzerland:

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2005.

Available at: http://www.ich.org/LOB/media/MEDIA1476.pdf. Last accessed July 22, 2010.

(14)

WZ/D/K'E/dZddDEdK,D/KdZW/K

'ϭϮZ/s/KE/

ŽŶƐŝŐůŝĂƚŝϯ'ĂĚŝƐƚĂŶnjĂĚŝϭϬŵŝŶƵƚŝ YdĐхϰϳϬŵƐĞĐ /^d/dh/ZD/^hZKZZdd/s

ƒ KEdZK>>KZd/E/E͕D'E^/K͕>/K͕^K/KWKd^^/K

ƒ KZZ''Z>ddZK>/d/;<н хϰDYͬ>͕DŐн хϭ͕ϴŵŐͬĚ>Ϳ

ƒ ^K^WEZ&ZD/KEKD/dEd/,WK^^KEKdZD/EZhE

>>hE'DEdK>Yd

• Z/s>hdZYdĐ WZ/D/ /E//ZdZddDEdK

• s>hdZZ/^,/KͬE&//K

WƌŽůŽŶŐĞĚYdĐ /ŶƚĞƌǀĂůŝŶĂŶĐĞƌdŚĞƌĂƉĞƵƚŝĐƌƵŐĞǀĞůŽƉŵĞŶƚ͗

ĞĨŝŶŝŶŐƌƌŚLJƚŚŵŝĐZŝƐŬŝŶDĂůŝŐŶĂŶĐLJ͕:ŽĂŶŶĂ D͘ƌĞůů WƌŽŐƌĞƐƐŝŶĂƌĚŝŽǀĂƐĐƵůĂƌŝƐĞĂƐĞƐϱϯ;ϮϬϭϬͿϭϲϰʹϭϳϮ

(15)

hZEd/>dZddDEdK

'ϭϮZ/s/KE/

ƒ ^dZddKDKE/dKZ''/K'>/>ddZK>/d/

ƒ KZZ''Z/^KE/;<н хϰDYͬ>͕DŐн хϭ͕ϴŵŐͬĚ>Ϳ

ƒ ddE/KE>>dZW/KEKD/dEd/,WK^^KEK

>>hE'ZYd

(16)

ŽƉŽƚƌĂƚƚĂŵĞŶƚŽ͗

KŐŶŝϭϬŵƐ ĂƵŵĞŶƚĂŶŽŝůƌŝƐĐŚŝŽĚŝdĚW ĚĞůϱͲϳй͗

YdĐ ϱϰϬŚĂхƌŝƐĐŚŝŽĚŝϲϯͲϵϳйƌŝƐƉĞƚƚŽĂϰϰϬ

YdĐ хϱϬϬŵƐ

YdĐ нϲϬŵƐ ƌŝƐƉĞƚƚŽĂůďĂƐĂůĞ

(17)

ƒ KE^/ZZK^W>//KE

ƒ KZZ''Zdhdd//WK^^//>/&ddKZ// Z/^,/K

Z/^,/K>sdK

'ϭϮZ/s/KE/

YdĐ хϱϬϬŵƐĞĐ ŽхϲϬŵƐĞĐ ƌŝƐƉĞƚƚŽĂůďĂƐĂůĞ

ƒ KZZ''Zdhdd//WK^^//>/&ddKZ// Z/^,/K

ƒ DĂŶƚĞŶĞƌĞ<н хϰDYͬ>͕DŐн хϭ͕ϴŵŐͬĚ>

ƒ ƐŽƐƉĞŶĚĞƌĞĨĂƌŵĂĐŝĐŽŶĐŽŵŝƚĂŶƚŝĐŚĞƉŽƐƐŽŶŽĂůůƵŶŐĂƌĞŝůYd

ƒ ^KDW/KEK^/EdKD/^K^WEZ>dZW/KEK>K'/

ƒ KWKKZZ/KE/&ddKZ/WZ/^WKEEd/͛WK^^//>

Z/WZEZ>dZW/ĐŽŶĚŽƐĂŐŐŝŽƌŝĚŽƚƚŽ^YdĐ фϰϳϬŵƐĞĐ ƉƌŽƐĞŐƵĞŶĚŽŵŽŶŝƚŽƌĂŐŐŝŽ

ƒs>hdZZ/^,/KͬE&//K

ůŝŶ WŚĂƌŵĂĐŽů dŚĞƌ͗ϮϬϭϬ&Ğď͖ϴϳ;ϮͿ͗ϭϲϲͲϳϰ͘ĚŽŝ͗ϭϬ͘ϭϬϯϴͬĐůƉƚ͘ϮϬϬϵ͘Ϯϭϰ͘ƉƵď ϮϬϬϵĞĐϵ͘ ǀĂůƵĂƚŝŽŶ ĂŶĚ ŵĂŶĂŐĞŵĞŶƚ ŽĨ ĐĂƌĚŝĂĐ ƐĂĨĞƚLJ ƵƐŝŶŐ

ƚŚĞ ĞůĞĐƚƌŽĐĂƌĚŝŽŐƌĂŵ ŝŶ ŽŶĐŽůŽŐLJ ĐůŝŶŝĐĂů ƚƌŝĂůƐ͗ ĨŽĐƵƐ ŽŶĐĂƌĚŝĂĐ ƌĞƉŽůĂƌŝnjĂƚŝŽŶ ;YdĐ ŝŶƚĞƌǀĂůͿ͘ DŽƌŐĂŶƌŽƚŚ :͕ ^ŚĂŚZZ͕ ^ĐŽƚƚ:t

(18)

KE>h^/KE/ʹ ϭ

'ĞƐƚŝŽŶĞͲ WƌĞǀĞŶnjŝŽŶĞ

• /ĚĞŶƚŝĨŝĐĂƌĞƉĂnjŝĞŶƚŝĂĚĂůƚŽƌŝƐĐŚŝŽĂƉƌŝŽƌŝ

• ůŝŵŝŶĂƌĞƚƵƚƚĞůĞĐŽŶĚŝnjŝŽŶŝĐŚĞĂŐŝƐĐŽŶŽƐƵů

ƉƌŽůƵŶŐĂŵĞŶƚŽĚĞůůĂƌŝƉŽůĂƌŝnjnjĂnjŝŽŶĞ

• WƌŝŵĂĚŝƐŽƐƉĞŶĚĞƌĞƵŶĂƚĞƌĂƉŝĂƐĂůǀĂǀŝƚĂ͕ĞůŝŵŝŶĂƌĞ

• WƌŝŵĂĚŝƐŽƐƉĞŶĚĞƌĞƵŶĂƚĞƌĂƉŝĂƐĂůǀĂǀŝƚĂ͕ĞůŝŵŝŶĂƌĞ

ƚƵƚƚĞůĞĂůƚƌĞƚĞƌĂƉŝĞĐŚĞŝŶƚĞƌĂŐŝƐĐŽŶŽ;ƌŝĐŽƌĚĂƌƐŝĂŶĐŚĞ

ĚŝŝŶƚĞƌĂnjŝŽŶŝƐƵĐŝƚŽĐƌŽŵŝͿ

• ŽŶƐŝĚĞƌĂƌĞĐŽŵĞĂůƚŽƌŝƐĐŚŝŽƉĞƌdĚWƵŶYdĐхϲϬŵƐ

ƌŝƐƉĞƚƚŽĂůďĂƐĂůĞŽхϱϬϬŵƐĂƐƐŽůƵƚŽ;ŵĂƌŝĐŽƌĚĂƌĞĐŚĞ

ŝůƌŝƐĐŚŝŽĐƌĞƐĐĞŝŶŵĂŶŝĞƌĂĞƐƉŽŶĞŶnjŝĂůĞͿ

(19)

KE>h^/KE/ʹ Ϯ

'ĞƐƚŝŽŶĞͲ ƚƌĂƚƚĂŵĞŶƚŽ

WĂnjŝĞŶƚĞŚĂŝůYdůƵŶŐŽ͗

• DŽŶŝƚŽƌŝnjnjĂnjŝŽŶĞ

• ŽƌƌĞŐŐĞƌĞĚŝƐŝŽŶŝĞ

• ŽŶƚƌĂƐƚĂƌĞŝƉĞƌƉŝƌĞƐƐŝĂ

• ZŝĚƵƌƌĞƐƚƌĞƐƐĂĚƌĞŶĞƌŐŝĐŽ;ŵĂĂƚƚĞŶnjŝŽŶĞĂďƌĂĚŝĐĂƌĚŝĂͿ

dŽƌƐŝŽŶĞĚŝWƵŶƚĂ

• ^ŽŵŵŝŶŝƐƚƌĂƌĞDĂŐŶĞƐŝŽƐŽůĨĂƚŽ

ͻ ^ĞƉĂnjŝĞŶƚĞďƌĂĚŝĐĂƌĚŝĐŽ͗ƉĂĐŝŶŐ ƚĞŵƉŽƌĂŶĞŽͬŝƐŽƉƌŽƚĞƌĞŶŽůŽ

(20)

ŽŵĂŶĚĞ͗

`ŽŵĞƐŝĚĞĨŝŶŝƐĐĞůĂƌĂĚŝĐĂƌĚŝĂ

`YƵĂůŝƐŽŶŽůĞĐĂƵƐĞĚĞůůĂƌĂĚŝĐĂƌĚŝĂ

`ŽŵĞƉƌĞǀĞŶŝƌĞůĂƌĂĚŝĐĂƌĚŝĂ

`ŽŵĞƚƌĂƚƚĂƌĞůĂƌĂĚŝĐĂƌĚŝĂ

(21)

ƌĂĚŝĐĂƌĚŝĂ ĚĞĨŝŶŝnjŝŽŶĞ

ĨƌĞƋƵĞŶnjĂĐĂƌĚŝĂĐĂфϲϬďĂƚƚŝƚŝͬŵŝŶƵƚŽ

>ĂďƌĂĚŝĐĂƌĚŝĂƉƵžĞƐƐĞƌĞĐŽƌƌĞůĂƚĂĂ͗

ƒ ĨĂƌŵĂĐŝ

ƒ ĨĂƌŵĂĐŝ

ƒ ƐŽƚƚŽƐƚĂŶƚĞĐĂƌĚŝŽƉĂƚŝĂĞƌĞůĂƚŝǀŽƚƌĂƚƚĂŵĞŶƚŽ

ƒ WƌĞŐƌĞƐƐĂŝƌƌĂĚŝĂnjŝŽŶĞŵĞĚŝĂƐƚŝŶŝĐĂŽ

ĐŽŝŶǀŽůŐŝŵĞŶƚŽĐĂƌĚŝĂĐŽĚĞůƚƵŵŽƌĞ

(22)

ƒ 'ĂϭϮĚĞƌŝǀĂnjŝŽŶĞ

ƒ ƐƚŽƌŝĂƉĞƌƐŽŶĂůĞĞĨĂŵŝŐůŝĂƌĞĚŝŵĂůĂƚƚŝĂĐĂƌĚŝĂĐĂ

ƒ ĞǀŝƚĂƌĞĨĂƌŵĂĐŝĐŚĞŝŶĚƵĐŽŶŽďƌĂĚŝĐĂƌĚŝĂ

ƒ ĐŽŶƚƌŽůůŽ ĞůĞƚƚƌŽůŝƚŝ

ŽŵĞƉƌĞǀĞŶŝƌĞ͍

d,>/KD/

;ĂŶŐŝŽŐĞŶĞƐŝƐ ŝŶŚŝďŝƚŽƌͿ ƒ KƌŵŽŶŝƚŝƌŽŝĚĞŝ

;ĂŶŐŝŽŐĞŶĞƐŝƐ ŝŶŚŝďŝƚŽƌͿ ƒ KƌŵŽŶŝƚŝƌŽŝĚĞŝ

W>/dy>

;ĂŶƚŝͲŵŝĐƌŽƚƵďƵůĞͿ

ƒ ƐĞŝůƉĂnjŝĞŶƚĞğďƌĂĚŝĐĂƌĚŝĐŽŽƉƌĞƐĞŶƚĂĚŝƐƚƵƌďŝ

ĚĞůůĂĐŽŶĚƵnjŝŽŶĞĚŝďĂƐĞ͕ŵŽŶŝƚŽƌĂŐŐŝŽ'Ğ

ƉƌĞƐƐŝŽŶĞĂƌƚĞƌŝŽƐĂĚƵƌĂŶƚĞůĞƉƌŝŵĞŽƌĞĚŝ

ŝŶĨƵƐŝŽŶĞ

ƒ^ĞƐƚŽƌŝĂĚŝĂůůĞƌŐŝĞĐŽŶƐŝŐůŝĂƚĂƉƌĞŵĞĚŝĐĂnjŝŽŶĞ

ĐŽŶĐŽƌƚŝĐŽƐƚĞƌŽŝĚŝ

Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy:

diagnosis, pathogenesis, and management. Circulation 2004;109:3122–31

(23)

d,>/KD/

;ĂŶŐŝŽŐĞŶĞƐŝƐ ŝŶŚŝďŝƚŽƌͿ

ŽŵĞƚƌĂƚƚĂƌĞ͍

ƒ ŶĞƐƐƵŶĂŝŶĚŝĐĂnjŝŽŶĞƐĞŝůƉĂnjŝĞŶƚĞğĂƐŝŶƚŽŵĂƚŝĐŽ

ƒ ƐĞŝƐŝŶƚŽŵŝƐŽŶŽůĞŐĂƚŝĂůůĂďƌĂĚŝĐĂƌĚŝĂ͕ƉƌĞŶĚĞƌĞ

ŝŶĐŽŶƐŝĚĞƌĂnjŝŽŶĞůĂƌŝĚƵnjŝŽŶĞĚĞůůĂĚŽƐĞŽ

ůΖŝŶƚĞƌƌƵnjŝŽŶĞĚĞůůĂƚĞƌĂƉŝĂ

ƒ ŶĞůŵŝĞůŽŵĂƌĞƐƉŽŶƐŝǀŽ ŝŶĚŝĐĂnjŝŽŶĞĂƉĂĐĞŵĂŬĞƌ

ƒ ŶĞůŵŝĞůŽŵĂƌĞƐƉŽŶƐŝǀŽ ŝŶĚŝĐĂnjŝŽŶĞĂƉĂĐĞŵĂŬĞƌ

ƐĞŶŽŶĐŝƐŽŶŽĂůƚĞƌŶĂƚŝǀĞ

ƒ WDƐĞs///

W>/dy>

;ĂŶƚŝͲŵŝĐƌŽƚƵďƵůĞͿ

ŝŶƚĞƌƌŽŵƉĞƌĞůĂĐŚĞŵŝŽƚĞƌĂƉŝĂƐĞĐŽŵƉĂƌĞsŽƐĞ

ůĂďƌĂĚŝĐĂƌĚŝĂğĞŵŽĚŝŶĂŵŝĐĂŵĞŶƚĞŝŶƐƚĂďŝůĞ

Yeh ET, Tong AT, Lenihan DJ, et al. Cardiovascular complications of cancer therapy:

diagnosis, pathogenesis, and management. Circulation 2004;109:3122–31

(24)

*UD]LHSHUO·DWWHQ]LRQH«

Riferimenti

Documenti correlati

For the functional activation of denervated and degenerated muscle (DDM) the technical requirements differ substantially from those for nerve stimulation. Due to the absence

There could be mentioned four following dimensions of accounting harmonization: (i) pre-formal harmonization (i.e. the need for accounting harmonization); (ii)

Recent studies have suggested that nonalcoholic fatty liver disease (NAFLD) is associated with an increased risk of heart rate –corrected QT interval prolongation and atrial

Software verification Integrated processes for the management of timeliness requirements (implicit and inherent to technical

The main findings of this study can be summarized as follows: the triple combination therapy with LPN/RTN, HQ, and AZT led to extreme QTc interval prolongation in 23% of

The EPBD requires Member States to set minimum energy performance requirements for technical building systems (means technical equipment for the heating, cooling, ventilation,

Conference on Harmonization; IMR: Index of microvascular resistance; MACE: Major adverse cardiac events; NSTEMI: Non-ST-elevation Acute Coronary Syndromes; Pa: Aortic pressure;

The use of this collective label is reserved for legal entities meeting the following regulatory requirements: registration on the French register of insurance,